Eli Lilly (NYSE: LLY) will present updated clinical and translational data at the San Antonio ... Harnessing the power of biotechnology ...
News
- Lilly to Present New HR+ Breast Cancer Data at SABCS 2025 | LLY Stock News
- County commission hears update on San Antonio area elections | TPR - Texas Public Radio
Bioscience-Medicine · Border & Immigration · Economy & Business · Crime ... County commission hears update on San Antonio area elections. Texas ...
- BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
... biotechnology company developing novel immunotherapies to ... San Antonio Breast Cancer Symposium (SABCS®) taking place December 9-12 ...
- Lilly to highlight progress across key programs in early and advanced hormone receptor ...
... San Antonio Breast Cancer Symposium (SABCS), taking place December 9–12 ... Harnessing the power of biotechnology, chemistry and genetic ...
- UT Health San Antonio scientists launch innovative therapy study to help Parkinson's ...
... San Antonio, will lead a phase 2, multisite clinical trial to test a ... biomedical sciences and public health that are leading change and ...